Vvedenskyi Dmytro, Volkova Nataliia, Babenko Natalya, Gaevska Yulia, Yukhta Mariia, Goltsev Anatoliy
Institute for Problems of Cryobiology and Cryomedicine, National Academy of Sciences of Ukraine, Kharkiv, Ukraine.
V. N. Karazin Kharkiv National University, Ukraine.
Reumatologia. 2022;60(3):213-219. doi: 10.5114/reum.2022.117842. Epub 2022 Jul 13.
The results of experimental and clinical studies in recent years indicate that the transplantation of multipotent mesenchymal stromal cells (MMSCs) is a possible approach for the "restoration" of the immune system of patients with autoimmune diseases, in particular, rheumatoid arthritis. However, the strength and duration of the effect vary greatly, which indicates incomplete correction of the tested parameters, thereby opening up the prospect of improving this method of treatment by choosing dose-time parameters and methods of their administration. The aim of this research was to determine the indices of cellular immunity in animals with adjuvant arthritis and therapy with cryopreserved MMSCs derived from adipose and cartilage tissues.
Adjuvant arthritis in male rats was modeled by subplantar administration of Freund's complete adjuvant. On day 7 of modeling, experimental animals were administered with saline (control group) or cryopreserved MMSCs from adipose or cartilaginous tissue locally or generalized. On day 28 after therapy the body weight, spleen index and cellularity, and content of CD3+, CD4+, CD8+, CD4+CD25+ cells in the spleen were determined.
In the control group of animals, the inflammation was pronounced, as evidenced by a significant increase in the studied parameters throughout the observation period. The use of cryopreserved MMSCs from adipose and cartilaginous tissues led to the restoration of T regulatory cells (Treg) on day 28. Generalized administration of cells had a more pronounced therapeutic effect compared to the animals with local administration. These data can be used to justify and develop a therapeutic approach to rheumatoid arthritis in clinical practice.
Cell therapy with cryopreserved MMSCs from investigated sources provided by both local and generalized administration to animals with adjuvant arthritis has a correcting effect on the cellular immunity.
近年来的实验和临床研究结果表明,多能间充质基质细胞(MMSC)移植是自身免疫性疾病患者,尤其是类风湿性关节炎患者免疫系统“恢复”的一种可能方法。然而,效果的强度和持续时间差异很大,这表明所测试参数的纠正并不完全,从而为通过选择剂量 - 时间参数及其给药方法来改进这种治疗方法开辟了前景。本研究的目的是确定佐剂性关节炎动物以及用来自脂肪和软骨组织的冷冻保存的MMSC进行治疗后的细胞免疫指标。
通过足底皮下注射弗氏完全佐剂建立雄性大鼠佐剂性关节炎模型。在建模第7天,给实验动物局部或全身注射生理盐水(对照组)或来自脂肪或软骨组织的冷冻保存的MMSC。治疗后第28天,测定体重、脾脏指数和细胞数以及脾脏中CD3 +、CD4 +、CD8 +、CD4 + CD25 +细胞的含量。
在动物对照组中,炎症明显,整个观察期内所研究参数显著增加证明了这一点。使用来自脂肪和软骨组织的冷冻保存的MMSC导致在第28天T调节细胞(Treg)恢复。与局部给药的动物相比,细胞的全身给药具有更明显的治疗效果。这些数据可用于在临床实践中证明和开发类风湿性关节炎的治疗方法。
对佐剂性关节炎动物进行局部和全身给药所提供的来自研究来源的冷冻保存的MMSC的细胞治疗对细胞免疫具有纠正作用。